Related Experiment Video
Updated: Jun 17, 2026

07:31
Characterization of Recombination Effects in a Liquid Ionization Chamber Used for the Dosimetry of a Radiosurgical Accelerator
Published on: May 9, 2014
Hybrid plan verification for intensity-modulated radiation therapy (IMRT) using the 2D ionization chamber array I'mRT
Barbara Dobler1, Natalia Streck, Elisabeth Klein
1Department of Radiotherapy, Regensburg University Medical Center, Regensburg, Germany. barbara.dobler@klinik.uni-regensburg.de
Physics in Medicine and Biology
|December 22, 2009
Summary
The I
Area of Science:
- Medical Physics
- Radiation Oncology
Background:
- The I'mRT MatriXX is a 2D ionization chamber array designed for intensity-modulated radiation therapy (IMRT) verification with perpendicular beam incidence.
- Its applicability for oblique beam incidence and hybrid plan verification in IMRT requires further evaluation.
Purpose of the Study:
- To assess the performance of the I'mRT MatriXX for oblique beam incidence in IMRT.
- To evaluate its suitability for hybrid plan verification of IMRT using original gantry angles.
Main Methods:
- Angular dependence was assessed using open fields at various gantry angles.
- Hybrid plan verification involved 17 clinical IMRT plans and one rotational plan.
- Calculations utilized validated pencil beam (PB), collapsed cone (CC), and Monte Carlo (MC) methods; measurements were performed on an Elekta SynergyS linear accelerator.
Main Results:
- Hybrid plan verification met gamma test criteria (4%/3 mm) in all instances.
- Success rates for 3%/3 mm and 3%/2 mm tolerances were 82-88% and 59-76%, respectively.
- The I'mRT MatriXX is suitable for IMRT hybrid plan verification within 3%/3 mm, with a relaxed 4% tolerance in low-dose regions outside the multileaf collimator (MLC).
Conclusions:
- The I'mRT MatriXX demonstrates applicability for IMRT hybrid plan verification, even with oblique beam incidence.
- The system provides reliable dosimetry for IMRT verification, with specific considerations for low-dose regions.
- These findings support the use of I'mRT MatriXX in advanced radiotherapy verification protocols.

